Trinity College Dublin scientists make breakthrough on gene therapy for eye disease described as 'silent thief of sight'

"The therapy protected key 'retinal ganglion cells' (RGCs) that are important in vision and improved their function in an animal model of glaucoma."

"In Europe, roughly one in 30 people aged between 40 and 80 years have glaucoma, and that rises to one in 10 in people over 90, so this is a really common condition that badly needs new treatment options."

Read at Irish Independent